Enhance your knowledge, skills and practice in molecular testing, emerging therapies, and targeted treatments in R/R #AML with this vodcast series hosted by Prof. Amer Zeidan.

All episodes available now 👉 buff.ly/ro4GLtX

#OncSky #HaemSky #MedEd

Prof. Amer Zeidan and guest experts dive into the latest innovations in molecular testing, emerging therapies & targeted treatments in R/R acute myeloid leukemia #AML in this vodcast series.

All episodes available now 👉 buff.ly/ro4GLtX

#OncSky #HaemOnc

What advancements in #CARTcell therapy have we seen in #rheumatology in 2025?

Sarah Onuora, Chief Editor of @natrevrheum.nature.com, discusses this and the other hot topics this year in our latest podcast.

Listen now 👉 buff.ly/t5vUVzy

#RheumSky #MedSky

#GLP1 therapies have dominated headlines this year, but what other advancements have caught the attention of Claire Greenhill, Chief Editor of @natrevendo.nature.com?

Find out in our latest podcast 👉 buff.ly/t5vUVzy

#Diabetes #EndoSky #UPFs

What were the hot topics in #cardiology in 2025?

Dr. Gregory Lim, Chief Editor of @natrevcardiol.nature.com discusses the topics that caught his attention this year.

Listen to the full podcast here 👉 buff.ly/t5vUVzy

#CardioSky #MedSky

With #ASH2025 at an end, continue your learning in #HaemOnc

Hear directly from #AML experts about innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients.

All episodes now available 👉 buff.ly/ro4GLtX

#HaemSky

Prof. Edoardo Savarino takes us through the highlights of the updated UEG and ESNM #dysphagia guidelines and the difference they could make to patient outcomes.

Listen now 🔉 buff.ly/CfJ9oay

#GastroSky #MedSky

25 years since the first phase 2 trial for the first #TKI, we reflect on this key breakthrough in the treatment of #CML with Dr. Jorge Cortes, who has been involved in the development of TKIs since the early days.

Listen now 🔉 buff.ly/afBarZg

#OncTwitter

Prof. Edoardo Savarino takes us through the highlights of the updated #UEG and #ESNM #dysphagia guidelines and the difference they could make to patient outcomes.

Listen now 🔉 buff.ly/CfJ9oay

#GastroSky

From #ESMO2025 - Prof. Christof Vulsteke shares study findings that position perioperative enfortumab vedotin plus #pembrolizumab as a new option for cisplatin-ineligible muscle-invasive #BladderCancer.

Watch the full interview 👉 buff.ly/RNdTu6h

#OncSky #MedNews

From #ESMO2025 - Dr. Erica Mayer highlights the benefit of treatment with #giredestrant plus #everolimus in patients with ER-positive, HER2-negative advanced #BreastCancer who have previously received a CDK4/6 inhibitor.

Watch now 👉 buff.ly/D0apqEh

#MedNews #OncSky

From #ESMO2025 - Prof. Jeanne Tie explains why ctDNA-guided treatment de-escalation could be considered in certain patients with #ColonCancer despite the trial not meeting its primary endpoint.

Watch the full interview 👉 buff.ly/EZ6gTh6

#OncSky #MedNews

From #UEGWeek 2025 - Yorick van de Pavert highlights the benefits of endoscopic #gastroenterostomy vs surgical for patients with malignant gastric outlet obstruction in findings from the ENDURO trial.

Watch the full interview 👉 buff.ly/Vwlo9CV

#GastricCancer